Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takashi Inozume

Showing results (1-10 of 89) with videos related to

Pageof 9
Sort By:
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 2, 2013
[Recent clinical trials of tumor immunotherapy]Takashi Inozume
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2024
[Ⅲ. Treatments for Skin Cancers Based on the Genetic Information]Takashi Inozume
Experimental Dermatology|November 16, 2022
Adoptive cell transfer therapy for melanomaTakashi Inozume
The British Journal of Dermatology|February 7, 2025
Focusing on antigen-specific T cellsTakashi Inozume, Satoshi Fukushima
Experimental Dermatology|January 27, 2023
Clues for developing next-generation cancer immunotherapyTakashi Inozume, Satoshi Fukushima
The Journal of Dermatology|December 27, 2023
Current surgical management for melanomaShigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
Current Treatment Options in Oncology|October 27, 2025
Current Surgical Management for Acral MelanomaShigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
The Journal of Dermatology|July 4, 2024
Does dermatophytosis of the feet cause acral melanoma?Takashi Inozume, Satoshi Fukushima, Tomoo Fukuda, et al.
The Journal of Investigative Dermatology|November 15, 2013
CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigensJunpei Furuta, Takashi Inozume, Kazutoshi Harada, et al.
The Journal of Investigative Dermatology|April 29, 2006
Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunityHiroshi Mitsui, Takashi Inozume, Reiko Kitamura, et al.
Pageof 9

Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
Nihon Rinsho Men'Eki Gakkai Kaishi = Japanese Journal of Clinical Immunology|July 2, 2013
[Recent clinical trials of tumor immunotherapy]Takashi Inozume
Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 21, 2024
[Ⅲ. Treatments for Skin Cancers Based on the Genetic Information]Takashi Inozume
Experimental Dermatology|November 16, 2022
Adoptive cell transfer therapy for melanomaTakashi Inozume
The British Journal of Dermatology|February 7, 2025
Focusing on antigen-specific T cellsTakashi Inozume, Satoshi Fukushima
Experimental Dermatology|January 27, 2023
Clues for developing next-generation cancer immunotherapyTakashi Inozume, Satoshi Fukushima
The Journal of Dermatology|December 27, 2023
Current surgical management for melanomaShigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
Current Treatment Options in Oncology|October 27, 2025
Current Surgical Management for Acral MelanomaShigeru Koizumi, Takashi Inozume, Yasuhiro Nakamura
The Journal of Dermatology|July 4, 2024
Does dermatophytosis of the feet cause acral melanoma?Takashi Inozume, Satoshi Fukushima, Tomoo Fukuda, et al.
The Journal of Investigative Dermatology|November 15, 2013
CD271 on melanoma cell is an IFN-γ-inducible immunosuppressive factor that mediates downregulation of melanoma antigensJunpei Furuta, Takashi Inozume, Kazutoshi Harada, et al.
The Journal of Investigative Dermatology|April 29, 2006
Polyarginine-mediated protein delivery to dendritic cells presents antigen more efficiently onto MHC class I and class II and elicits superior antitumor immunityHiroshi Mitsui, Takashi Inozume, Reiko Kitamura, et al.
Pageof 9